Search hospitals > Florida > Fort Lauderdale
Novartis Investigative Site
Claim this profileFort Lauderdale, Florida 33324
Global Leader in Psoriasis
Conducts research for Chronic Obstructive Pulmonary Disease
Conducts research for Obstructive Lung Diseases
Conducts research for Heart Failure
Conducts research for Lung Disease
83 reported clinical trials
3 medical researchers
Summary
Novartis Investigative Site is a medical facility located in Fort Lauderdale, Florida. This center is recognized for care of Psoriasis, Chronic Obstructive Pulmonary Disease, Obstructive Lung Diseases, Heart Failure, Lung Disease and other specialties. Novartis Investigative Site is involved with conducting 83 clinical trials across 84 conditions. There are 3 research doctors associated with this hospital, such as Frank McGrew, M.D., Farhad Rafii, MD, and Joel Landzberg.Top PIs
Frank McGrew, M.D.Stern Cardiovascular6 years of reported clinical research
Studies Heart Failure
Studies Cardiovascular Disease
3 reported clinical trials
4 drugs studied
Farhad Rafii, MDInterventional Cardiology Medical Group2 years of reported clinical research
Studies Cardiovascular Disease
Studies Atherosclerosis
3 reported clinical trials
3 drugs studied
Joel LandzbergNovartis Investigative Site4 years of reported clinical research
Studies Cardiovascular Disease
1 reported clinical trial
1 drug studied
Clinical Trials running at Novartis Investigative Site
Giant Cell Arteritis
Cardiovascular Disease
Polymyalgia Rheumatica
Age-Related Macular Degeneration
Osteoarthritis
Autoimmune Inflammation
Inflammation
Acute Coronary Syndrome
Syndrome
Atherosclerosis
Secukinumab
for Giant Cell Arteritis
This is a phase III study of efficacy and safety of secukinumab versus placebo, in combination with glucocorticoid taper regimen, in patients with giant cell arteritis (GCA)
Recruiting1 award Phase 37 criteria
Secukinumab
for Polymyalgia Rheumatica
This trial tests secukinumab injections for adults with relapsed Polymyalgia Rheumatica (PMR). The treatment aims to reduce inflammation by calming the immune system. Researchers will compare the effectiveness and safety of secukinumab over a period of time. Secukinumab has been shown to improve signs and symptoms in various inflammatory conditions such as ankylosing spondylitis and psoriatic arthritis in multiple clinical trials.
Recruiting1 award Phase 36 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Novartis Investigative Site?
Novartis Investigative Site is a medical facility located in Fort Lauderdale, Florida. This center is recognized for care of Psoriasis, Chronic Obstructive Pulmonary Disease, Obstructive Lung Diseases, Heart Failure, Lung Disease and other specialties. Novartis Investigative Site is involved with conducting 83 clinical trials across 84 conditions. There are 3 research doctors associated with this hospital, such as Frank McGrew, M.D., Farhad Rafii, MD, and Joel Landzberg.